참고문헌
- Ardizzone S, Bianchi PG. Biologic therapy for inflammatory bowel disease. Drugs 2005. 65: 2253-2286. https://doi.org/10.2165/00003495-200565160-00002
- Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol. 2003. 3: 521-533. https://doi.org/10.1038/nri1132
- Camuesco D, Galvez J, Nieto A, Comalada M, Rodriguez-Cabezas ME, Concha A, Xaus J, Zarzuelo A. Dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, attenuates colonic inflammation in rats with DSS-induced colitis. J Nutr. 2005. 135: 687-694.
- Copper HS, Murthy SNS, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest. 1993. 69: 238-249.
- Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology. 1998. 115: 182-205. https://doi.org/10.1016/S0016-5085(98)70381-6
- Hendrickson BA, Gokhale R, Cho JH. Clinical aspects and Pathophysiology of inflammatory bowel disease. Clin Microbiol Rev. 2002. 15: 79-94. https://doi.org/10.1128/CMR.15.1.79-94.2002
-
Ishiguro K, Ando T, Maeda O, Hasegawa M, Kadomatsu K, Ohmiya N, Niwa Y, Xavier R, Goto H. Paeonolattenuates TNBS-induced colitis by inhibiting NF-
${\kappa}B$ and STAT1 transactivation. Toxicol Appl Pharmacol. 2006. 217: 35-42. https://doi.org/10.1016/j.taap.2006.07.002 - Kim SJ, Kim YG, Kim DS, Jeon YD, Kim MC, Kim HL, Kim SY, Jang HJ, Lee BC, Hong SH, Um JY. Oldenlandia diffusa Ameliorates Dextran Sulfate Sodium-Induced Colitis Through Inhibition of NF-kappa B Activation. Am J Chin Med. 2011. 39: 957-969. https://doi.org/10.1142/S0192415X11009330
- Kim SJ, Kim KW, Kim DS, Kim MC, Jeon YD, Kim SG, Jung HJ, Jang HJ, Lee BC, Chung WS, Hong SH, Chung SH, Um JY. The Protective Effect of Cassia obtusifolia on DSS-Induced Colitis. Am J Chin Med. 2011. 39: 565-577. https://doi.org/10.1142/S0192415X11009032
- Li Y, de Haar C, Chen M, Deuring J, Gerrits MM, Smits R, Xia B, Kuipers EJ, van der Woude J. Disease-related expression of the IL-6/STAT3/SOCS3 signaling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis. Gut. 2010. 59: 227-235. https://doi.org/10.1136/gut.2009.184176
- Lin TY, Liu YC, Jheng JR, Tsai HP, Jan JT, Wong WR, Horng JT. Anti-enterovirus 71 activity screening of Chinese herbs with anti-infection and inflammation activities. Am J Chin Med. 2009. 37: 143-158. https://doi.org/10.1142/S0192415X09006734
- MacDonald TT, Murch SH. Aetiology and pathogenesis of chronic inflammatory bowel disease. Baillieres Clin. Gastroenterol. 1994. 8: 1-34.
- Murthy SN, Cooper HS, Shim H, Shah RS, Ibarahim SA, Sedergran DJ. Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig Dis Sci. 1993. 38: 1722-1734. https://doi.org/10.1007/BF01303184
- Ramakers JD, Verstege MI, Thuijls G, Te Velde AA, Mensink RP, Plat J. The PPARgamma agonist rosiglitazone impairs colonic inflammation in mice with experimental colitis. J Clin Immunol. 2007. 27: 275-283. https://doi.org/10.1007/s10875-007-9074-2
- Roh SS, Kim SH, Lee YC, Seo YB. Effects of radix adenophorae and cyclosporine A on an OVA-induced murine model of asthma by suppressing to T cells activity, eosinophilia, and bronchial hyperresponsiveness. Mediators Inflamm. 2008. 2008: 781425.
- Rufo PA, Bousvaros A. Current therapy of inflammatory bowel disease in children. Paediatr Drugs. 2006. 8: 279-302. https://doi.org/10.2165/00148581-200608050-00002
- Sato K, Ohkura S, Kitahara Y, Ohama T, Hori M, Sato M, Kobayashi S, Sasaki Y, Hayashi T, Nasu T, Ozaki H. Involvement of CPI-17 downregula in the dysmotility of the colon from dextran sodium sulfate-induced experimental colitis in a mouse model. Neurogastroenterol Motil. 2007. 19: 504-514. https://doi.org/10.1111/j.1365-2982.2007.00911.x
- Sandborn, WJ, Targan SR. Biologic therapy of inflammatory bowel disease. Gastroenterology. 2002. 122: 1592-1608. https://doi.org/10.1053/gast.2002.33426
- Talhouk RS, Karam C, Fostok S, El-Jouni W, Barbour EK. Anti-inflammatory bioactivities in plant extracts. J Med Food. 2007. 10: 1-10. https://doi.org/10.1089/jmf.2005.055
- Yang SK. Current status and clinical characteristics of inflammatory bowel disease in Korea. Korean J Gastroenterol. 2002. 40: 1-14.
- Zheng P, Niu FL, Liu WZ, Shi Y, Lu LG. Anti-inflammatory mechanism of oxymatrine in dextran sulfate sodiuminduced colitisofrats. World J Gastroenterol. 2005. 11: 4912-4915.